## GEV: GE Vernova Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 3.8% below STRENGTH zone (4.0-10.0%); PEG 1.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-7.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($590.63)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Douglas Lane & Associates LLC Trims Stock Holdings in GE Vernova Inc. $GEV**
- Source: MarketBeat | 20251222T090623 | Somewhat-Bullish | Relevance: 100%
- Douglas Lane & Associates LLC recently reduced its stake in GE Vernova Inc. (NYSE:GEV) by 26.8% in the third quarter, now owning 10,193 shares valued at $6,268,000. Despite this reduction, other institutional investors like Norges Bank and Arrowstreet Capital Limited Partnership significantly increased their holdings. GE Vernova's stock has seen a 2.9% rise, trades at $658.03, and received several analyst upgrades, though some express neutral to negative sentiment regarding its valuation and recent performance.

**2. GE Vernova (GEV) Gets Higher Price Targets from Wells Fargo and UBS**
- Source: Finviz | 20251221T144856 | Bullish | Relevance: 100%
- Wells Fargo and UBS have both raised their price targets for GE Vernova (GEV) due to strong performance and optimistic outlooks for its Power and Electrification segments. Wells Fargo increased its price target from $717 to $831, citing higher EBITDA and EPS forecasts, while UBS raised its target from $760 to $835, believing the company's long-term guidance may be too cautious. Both firms maintain positive ratings, anticipating significant growth and higher margins for GE Vernova.

**3. Clarity Financial LLC Has $20.19 Million Holdings in GE Vernova Inc. $GEV**
- Source: MarketBeat | 20251221T090747 | Somewhat-Bullish | Relevance: 100%
- Clarity Financial LLC significantly trimmed its stake in GE Vernova Inc. (NYSE:GEV) by 29.2% in the third quarter, reducing its holdings to 32,840 shares valued at approximately $20.19 million. Despite this reduction, GE Vernova remains a substantial part of Clarity Financial's portfolio. The article also highlights recent positive analyst sentiment, with multiple firms issuing "buy" or "overweight" ratings and increasing price targets for GEV, alongside the company's financial performance including an EPS miss but a revenue beat and a dividend increase.

**4. Voya Investment Management LLC Has $78.01 Million Position in GE Vernova Inc. $GEV**
- Source: MarketBeat | 20251220T140813 | Somewhat-Bullish | Relevance: 100%
- Voya Investment Management LLC reduced its stake in GE Vernova Inc. by 7.4% in Q3, owning 126,859 shares valued at $78.01 million. Meanwhile, other large institutions like Norges Bank significantly increased their holdings. Analyst sentiment for GE Vernova is moderately positive, with a consensus "Moderate Buy" rating and a target price of $690.56, despite a Q3 EPS miss but a revenue beat and a dividend increase.

**5. GE Vernova Inc. $GEV Shares Sold by Financial Enhancement Group LLC**
- Source: MarketBeat | 20251220T095854 | Somewhat-Bullish | Relevance: 100%
- Financial Enhancement Group LLC significantly reduced its stake in GE Vernova Inc. (NYSE:GEV) by 51.1% in Q3, selling 1,784 shares and retaining 1,706 shares valued at $1.07 million. Despite this, GE Vernova has seen multiple analyst upgrades and a consensus "Moderate Buy" rating with a price target of $690.56. The company also recently doubled its quarterly dividend to $0.50, representing an annualized dividend of $2.00 and a yield of approximately 0.3%.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 10, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | RBC Capital | $761 | $761 | 0% |
| 2025-12-22 | Jefferies | $830 | $815 | +2% |
| 2025-12-18 | Jefferies | $815 | $736 | +11% |
| 2025-12-17 | Goldman Sachs | $840 | $735 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | RBC Capital | main | Outperform |
| 2025-12-22 | Jefferies | main | Buy |
| 2025-12-18 | Jefferies | up | Buy |
| 2025-12-17 | Goldman Sachs | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (+0.6%)
- FMR, LLC: 8.4% (-8.5%)
- Blackrock Inc.: 7.4% (+1.8%)
- JPMORGAN CHASE & CO: 4.2% (+641.6%)
- State Street Corpora: 4.1% (+1.3%)

### Key Risks

1. High beta (2.68) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Momentum deterioration: MRS_20 falling (-7.4% 5d) with bearish MACD, trend may be turning.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Analyst target momentum: 10 raises (avg +9%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Forward P/E 50.1x attractive for 72% earnings growth. Analyst sentiment positive (10 raises, avg +9%). Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $180.2B |
| Beta | 1.00 |
| 52W Range | $252.25 - $731.00 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 50.1 |
| Current P/E | 86.2 |
| YoY Growth | 72.2% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 11.2% to 3.8% (-7.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.2pp (needs >4.0% for momentum thesis). MRS_5 at 0.1% confirms short-term momentum alignment. AM_20 at 4.4% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56. OFD pattern: -MLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.83% (CS: 78) | Neutral |
| RSI_14 | 55.8 | Neutral |
| MACD Histogram | -0.14 | Bearish |
| vs SMA20 | 1.044x | Above |
| vs SMA50 | 1.098x | Above |
| vs SMA200 | 1.264x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $661.53
- **Stop Loss:** $590.63 (10.7% risk)
- **Target:** $732.43 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 12
- **Position Value:** $7,938.36
- **Portfolio %:** 7.94%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-21 (Est: $3.14)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.86 | $1.64 | -11.7% |
| 2025Q2 | $1.63 | $1.86 | +14.3% |
| 2025Q1 | $0.61 | $0.91 | +49.1% |
| 2024Q4 | $2.49 | $1.73 | -30.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*